Clinical Trials Logo

Clinical Trial Summary

At present, pulmonary diffusion and target antifungal concentrations for APC in patients with sarcoidosis or chronic obstructive pulmonary disease (COPD) are unknown.


Clinical Trial Description

Knowledge of these elements is however an essential prerequisite for optimizing the dosages in these contexts. The main objective of the study is to quantify the diffusion of antifungals in the lower respiratory tract in patients treated for pulmonary aspergillosis in the context of underlying chronic respiratory disease. Determining this level of diffusion will make it possible to deduce the plasma concentrations to be achieved in patients and to identify the molecules with the best diffusion profile. The concentration of antifungals in the lungs will be measured from 3 types of samples: - Sputum obtained by expectoration. These samples will make it possible to quantify the diffusion at the level of the upper and lower respiratory tree. - Bronchial aspirations. These samples will make it possible to quantify the diffusion at the level of the deep respiratory tree. - Bronchoalveolar lavage fluid, which will quantify the diffusion at the level of the deep respiratory tree and the ELF. Blood samples will be taken simultaneously so as to determine the percentage of diffusion from the plasma to the lung. All these samples will be taken as part of the standard care of patients, the lung samples having the main use of mycological monitoring, the blood samples having the main use of pharmacological and serological monitoring. Lung samples will also be taken routinely for pharmacological monitoring, in order to measure antifungal concentrations at the site of infection. Mycological monitoring will consist of measuring the fungal load in the broncho-respiratory secretions as well as carrying out an antifongigram in the event of isolation of Aspergillus spp. The possible association between plasma and pulmonary concentrations of antifungals on the one hand, and mycological and clinical markers of treatment efficacy on the other hand, will also be investigated. The mycological markers of efficacy will be the results of mycological monitoring (culture of broncho-respiratory secretions and aspergillus serology). The clinical markers will be the pulmonary imaging results obtained as part of the management of these patients. The identification of such combinations should allow target concentrations of antifungals to be defined and, where appropriate, antifungal dosage recommendations specific to the treatment of PCA in patients with chronic respiratory disease to be defined. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05064605
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Yurdagül Yuzunhan, MD PhD
Phone +33148956467
Email [email protected]
Status Not yet recruiting
Phase
Start date October 1, 2021
Completion date October 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02894190 - Development and Validation of the BVQ N/A
Not yet recruiting NCT05054127 - Clinical Characteristics And Outcome Of COVID-19 Infection In Patients With Chronic Respiratory Diseases.
Recruiting NCT04566523 - TeleRehabilitation for Patients With Chronic Respiratory Failure.
Recruiting NCT04139356 - The Effect of Spontaneous Respiration on Pulse-oximetry Measurements N/A
Completed NCT03880630 - Inspiratory Muscle Activation Pattern Analysis in Assisting Precision in Inspiratory Muscle Training in Patients With Chronic Respiratory Disease N/A
Recruiting NCT03728595 - Validation of a Predictive Score for HAST
Completed NCT03294057 - Collaborative Care With Smart Health Management Program for Patients With Chronic Illness N/A
Completed NCT03704935 - Long Term Effects and of a Pulmonary Rehabilitation Maintenance Program
Recruiting NCT03797183 - Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
Completed NCT04623762 - Yoga On Dyspnea, Sleep And Fatıgue In Chronıc Respıratory Dıseases N/A
Not yet recruiting NCT04911764 - Three-min Step Test and Exercise Desaturation Detection in Chronic Respiratory Insufficiency Patients N/A
Completed NCT02715219 - The Effect of an AEP on Patient's Knowledge Regarding Asthma Disease and Inhaler Technique: RCT N/A
Completed NCT03799666 - (Re)Vitalizing Pulmonary Rehabilitation for Patients With Chronic Respiratory Diseases N/A
Completed NCT03188588 - Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients
Completed NCT03930511 - Telemonitoring Physical Activity in Daily Life on Chronic Respiratory Patients N/A
Recruiting NCT04373070 - Quality-of-Life Management for COPD Patients N/A
Enrolling by invitation NCT03476473 - Early Detection of Respiratory Disorders in Psychosis
Recruiting NCT04851808 - Chronic Respiratory Disease Burden in Bangladesh
Active, not recruiting NCT03420209 - The Effect of Proprioceptive Neuromuscular Facilitation (PNF) Technique for Children With Chronic Pulmonary Diseases. N/A
Recruiting NCT03153800 - Autologous Bronchial Basal Cells Transplantation for Treatment of CRD Including COPD, BE and PF Early Phase 1